"It's very clear that EN1 is a really important factor behind the aggressiveness of pancreatic cancer."

Laboratory findings have set the stage for a clinical trial investigating a drug for pancreatic cancer that has spread to the liver.

Newly discovered biomarkers may offer a way to predict if pancreatic cysts will turn to cancer or remain benign.

A new approach that combines a gel-like radiation implant and chemotherapy completely dissolved pancreatic cancer in 80% percent of mice.

A new "time machine" may offer a way to reverse the course of pancreatic cancer before it spreads.

When combined with immunotherapy, some antidepressants stopped the growth of pancreatic and colon cancers in mice. In some cases tumors even disappeared.

The MasSpec Pen is 100x as fast as previous methods at identifying healthy and cancerous pancreatic tissue, giving patients the greatest chance of survival.

Personalized cancer vaccines made using DNA can program the immune system to attack tumors, including breast and pancreatic cancers, researchers report.

Personalized cancer vaccines made using DNA can program the immune system to attack tumors, including breast and pancreatic cancers, researchers report.

Mutations of the KRAS gene occur in more than 90% of pancreatic cancer cases and drastically reduce response to immunotherapy.